Università degli Studi di Catania seeks a researcher to investigate incretin receptors GIPR and GLP1R in breast cancer over a two-year period. The project will analyze receptor expression in tumor samples and transcriptomic datasets, including TCGA, and integrate findings with insulin signaling to define a metabolic network related to obesity and insulin resistance.
The role includes in vitro studies with GIP and GLP-1 agonists to assess effects on proliferation and oncogenic signaling, aiming
📌 Breast Cancer GIPR (Italia)
🏢 Altro
📍 Italia